Medpace Holdings, Inc.

NASDAQ:MEDP

294.9 (USD) • At close May 30, 2025
Bedrijfsnaam Medpace Holdings, Inc.
Symbool MEDP
Munteenheid USD
Prijs 294.9
Beurswaarde 8,475,897,840
Dividendpercentage 0%
52-weken bereik 250.05 - 459.77
Industrie Diagnostics & Research
Sector Healthcare
CEO Dr. August James Troendle M.D.
Website https://www.medpace.com

An error occurred while fetching data.

Over Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology,

Vergelijkbare Aandelen

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

75.56 USD

Premier, Inc. logo

Premier, Inc.

PINC

22.98 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

147.26 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

16.93 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

19.82 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

134.86 USD

Alkermes plc logo

Alkermes plc

ALKS

30.61 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

30.67 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)